Weiss Multi-Strategy Advisers’s BeOne Medicines Ltd ONC Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-8,052	Closed	-$1.77M	–	755
2022 Q4	$1.77M	Buy	+8,052	New	+$1.48M	0.05%	401
2022 Q3	–	Sell	-5,532	Closed	-$895K	–	786
2022 Q2	$895K	Buy	+5,532	New	+$864K	0.03%	492

Other funds holding ONC

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

CII

Capital International Inc Los Angeles, California $14.3B AUM 34.19% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Weiss Multi-Strategy Advisers's ONC Position: Q1 2023 in Review

Weiss Multi-Strategy Advisers sold out of BeOne Medicines Ltd (ONC) in Q1 2023, closing a stake of 8,052 shares — an estimated $1.77M sold.

Weiss Multi-Strategy Advisers first reported a position in ONC in Q2 2022 and held it in 2 quarters. The position peaked at $1.77M in Q4 2022. 220 funds tracked by Wall St. Rank hold ONC as of Q1 2023.

Weiss Multi-Strategy Advisers reported no remaining BeOne Medicines Ltd position as of Q1 2023 after selling out during the quarter.
Weiss Multi-Strategy Advisers sold 8,052 BeOne Medicines Ltd shares in Q1 2023, an estimated $1.77M.
Weiss Multi-Strategy Advisers first reported a position in BeOne Medicines Ltd in Q2 2022 and held it in 2 quarters.
Weiss Multi-Strategy Advisers's BeOne Medicines Ltd position peaked at $1.77M in Q4 2022.
220 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q1 2023.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q1 2023, filed 15 May 2023.